Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Worse Prognosis in Cervical Cancers.
Uiju ChoHae-Mi KimHong Sik ParkOh-Joo KwonAhwon LeeSeong-Whan JeongPublished in: PloS one (2016)
High nuclear expression of GS28 is associated with poor prognosis in early-stage cervical cancer patients. GS28 might be a novel prognostic marker and a potential therapeutic target in cervical cancer treatment.